You just read:

Optimer Pharmaceuticals and AstraZeneca Collaborate to Commercialize Fidaxomicin for Clostridium Difficile Infection in Latin America

News provided by

Optimer Pharmaceuticals, Inc.

Dec 03, 2012, 08:00 ET